Valuate Health Consultancy – Medium

Valuate Health Consultancy

Published in
This Way In

CMS arms Medicaid with a new drug payment program

Value-based purchasing elevates state contracts for manufacturers

Dec 22, 2020

CMS arms Medicaid with a new drug payment program

Dec 22, 2020

Published in
This Way In

Provider visits return to pre-pandemic level for some specialties

Valuate Health Consultancy reviewed recent report to identify key takeaways that may affect strategic thinking for manufacturers

Oct 22, 2020

Provider visits return to pre-pandemic level for some specialties

Oct 22, 2020

Published in
This Way In

Diverse COVID-19 vaccines advance toward market

The strategies, pricing, and prioritization behind COVID-19 vaccine contenders allow for unparalleled development speed

May 27, 2020

Diverse COVID-19 vaccines advance toward market

May 27, 2020

Published in
This Way In

Managing conflicting cancer care preferences during COVID

Divergence exists between providers who embrace home infusion of chemotherapy and those refuse to even consider it.

Apr 16, 2020

Managing conflicting cancer care preferences during COVID

Apr 16, 2020

Published in
This Way In

CAR T Conundrum: Reimbursement Shadows Clinical Value

Although CAR T-cell therapy offers new promise, high costs, cash flow issues, and lack of real-world evidence have stunted product uptake

Feb 4, 2020

CAR T Conundrum: Reimbursement Shadows Clinical Value

Feb 4, 2020

Published in
This Way In

Include patients, improve outcomes

The impact of patient-reported outcomes (PROs) on improving quality is a recent but rapidly advancing story

Jan 8, 2020

Include patients, improve outcomes

Jan 8, 2020

Published in
This Way In

The OCM Crossroads

The Oncology Care Model (OCM) is the leading Medicare oncology VBC program, and it’s about to change course

Dec 11, 2019

The OCM Crossroads

Dec 11, 2019

Published in
This Way In

Price Transparency in Real Time

Solutions to improve price transparency are affecting clinical practice and will continue to evolve

Nov 26, 2019

Price Transparency in Real Time

Nov 26, 2019

Published in
This Way In

Migraine Management on the Move

Migraine treatment is an explosive market, and payers need help keeping up

Nov 12, 2019

Migraine Management on the Move

Nov 12, 2019

Published in
This Way In

Creating 21st Century HCEI

Learn how to optimize your HCEI communications to boost product value

Oct 16, 2019

Creating 21st Century HCEI

Oct 16, 2019

Published in
This Way In

Sustainable Financing for Gene Therapy

Recently, CIGNA launched a novel platform named Embarc Benefit Protection to help isolate the financial risk of costly therapies.

Sep 17, 2019

Sustainable Financing for Gene Therapy

Sep 17, 2019

Published in
This Way In

Connect With High-Control VA/DoD Accounts

Engaging with federal customers requires expert analysis and a specialized approach

Sep 8, 2019

Connect With High-Control VA/DoD Accounts

Sep 8, 2019

Published in
This Way In

How Pharma Can Support Diversity and Inclusion

Pharma has the power to influence tremendous gains for diversity and inclusion in healthcare

Aug 21, 2019

How Pharma Can Support Diversity and Inclusion

Aug 21, 2019

Published in
This Way In

Expanding Value With Total Cost of Care

Impact on total cost of care is considered an essential metric in today’s value-based payment environment

Aug 16, 2019

Expanding Value With Total Cost of Care

Aug 16, 2019

Published in
This Way In

Defining Value in a Multi-Stakeholder Environment

In today’s rapidly evolving market landscape, the market access value proposition requires an approach that is both wide and deep.

Aug 16, 2019

Defining Value in a Multi-Stakeholder Environment

Aug 16, 2019

Valuate Health Consultancy

Valuate Health Consultancy

Market access strategy consultancy: We optimize value strategy and commercialization in the healthcare industry.

Following

Help
Status
About
Careers
Press
Blog
Privacy
Rules
Terms
Text to speech